Michael Leane

Michael Leane

Auto-generated profile, based on publicly available information

Michael Leane

A Drug Product Science & Technology (DPST), Bristol-Myers Squibb , Moreton , UK

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2018 in Pharmaceutical Development and Technology
Verified
Journal Article
Closed access
MLMichael Leane
Michael Leane
KPKendal Pitt
Kendal Pitt
GRGavin K. Reynolds
Gavin K. Reynolds
NDNeil Dawson
Neil Dawson
IZIris Ziegler
Iris Ziegler
TSThe Manufacturing Classification Sy
The Manufacturing Classification Sy
Following the first Manufacturing Classification System (MCS) paper, the team conducted surveys to establish which active pharmaceutical ingredient (API) properties were important when selecting or modifying materials to enable an efficient and robust pharmaceutical manufacturing process. The most commonly identified factors were (1) API particle size: small particle sizes are known to increase risk of processing issues; (2) Drug loading in the formulation: high drug loadings allow less opportunity to mitigate poor API properties through the use of excipients. The next step was to establish linkages with process decisions by identifying publicly-available proxies for these important parameters: dose (in place of drug loading) and BCS class (in place of particle size). Poorly-soluble API were seen as more likely to have controlled (smaller) particle size than more highly soluble API. Analysis of 435 regulatory filings revealed that higher doses and more poorly-soluble API was associated with more complex processing routes. Replacing the proxy factors with the original parameters should give the opportunity to demonstrate stronger trends. This assumption was tested by accessing a dataset relating to commercial tablet products. This showed that, for dry processes, a larger particle size was associated with higher achievable drug loading as determined by percolation threshold.